Entourage Health Corp. (ETRGF)
| Previous Close | 0.0097 |
| Open | 0.0080 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0080 - 0.0121 |
| 52 Week Range | 0.0021 - 0.0210 |
| Volume | |
| Avg. Volume | 21,842 |
| Market Cap | 3.725M |
| Beta (5Y Monthly) | 1.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2700 |
| Earnings Date | May 27, 2024 - May 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireEntourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®
Entourage Unveils Exciting New Product Offerings Diversifying the Company’s Signature BrandsDime Bag® Widens Reach: Popular Offerings Now Across Alberta TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), an established Canadian producer and distributor of award-winning cannabis products, today unveiled the expansion of its product portfolio. Entourage also announced the expansion of Dime Bag-branded pre-rolls in
Simply Wall St.Entourage Health Full Year 2023 Earnings: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022)
Entourage Health ( CVE:ENTG ) Full Year 2023 Results Key Financial Results Revenue: CA$40.7m (flat on FY 2022). Net...
- GlobeNewswire
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
Strategic Cost Management Signals Stronger Financial Health and Future StabilityGross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A declined 14% compared to the previous year.Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage"
